OBIO · Categories · Form 4

OBIO - SEC Form 4 insider transactions

Orchestra BioMed Holdings Inc. (OBIO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for OBIO

• 11d
  Director Mack John Prosper covered exercise/tax liability with 4,885 shares, decreasing direct ownership by 7% to 66,544 units (SEC Form 4) (tax liability)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 11d
  Director Fain Eric S covered exercise/tax liability with 5,145 shares (SEC Form 4) (withholding obligation)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 11d
  Director Pacitti David covered exercise/tax liability with 3,761 shares, decreasing direct ownership by 6% to 54,750 units (SEC Form 4) to satisfy withholding tax

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 21d
  Officer Sherman Darren sold $61,350 worth of shares (15,000 units at $4.09) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,154,327 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 54d
  Officer Sherman Darren sold $64,050 worth of shares (15,000 units at $4.27) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,169,327 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 61d
  Director Fain Eric S was granted 17,327 shares and covered exercise/tax liability with 4,261 shares (SEC Form 4) to satisfy tax liability

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 61d
  Director Pacitti David was granted 17,327 shares and covered exercise/tax liability with 3,784 shares, increasing direct ownership by 30% to 58,511 units (SEC Form 4) (for tax liability)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 61d
  Director Cleary Chris covered exercise/tax liability with 3,510 shares, decreasing direct ownership by 10% to 33,391 units (SEC Form 4) to cover withholding tax

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 61d
  Director Connealy Pamela Ann was granted 17,327 shares, increasing direct ownership by 36% to 66,038 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 61d
  SEC Form 4 filed by Director Aryeh Jason

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 61d
  Director Mack John Prosper was granted 34,653 shares and covered exercise/tax liability with 3,510 shares, increasing direct ownership by 77% to 71,429 units (SEC Form 4) to satisfy withholding obligation

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 74d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 36,352 shares, decreasing direct ownership by 6% to 593,065 units (SEC Form 4) to satisfy tax liability

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 74d
  Officer Hochman David P covered exercise/tax liability with 6,566 shares, decreasing direct ownership by 0.31% to 1,060,746 units (SEC Form 4) (tax withholding)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 84d
  Officer Sherman Darren sold $58,050 worth of shares (15,000 units at $3.87) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,184,327 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 88d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 3,076 shares, decreasing direct ownership by 0.49% to 629,417 units (SEC Form 4) (for tax liability)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 88d
  Officer Sherman Darren covered exercise/tax liability with 4,925 shares, decreasing direct ownership by 0.41% to 1,199,327 units (SEC Form 4) to satisfy tax liability

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 118d
  Large owner Rtw Investments, Lp exercised 1,250,032 in-the-money shares at a strike of $0.00 and sold $132 worth of shares (32 units at $4.13) (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 151d
  SEC Form 4 filed by Sherman Darren

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 151d
  SEC Form 4 filed by Aiello Joshua

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 151d
  SEC Form 4 filed by Hochman David P

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 193d
  SEC Form 4 filed by Principal Accounting Officer Aiello Joshua

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 193d
  Officer Sherman Darren was granted 397,000 shares, increasing direct ownership by 47% to 1,237,569 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 193d
  Chief Financial Officer Taylor Andrew Lawrence was granted 181,000 shares, increasing direct ownership by 40% to 632,493 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 193d
  Officer Hochman David P was granted 504,000 shares, increasing direct ownership by 88% to 1,076,467 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 200d
  Director Cleary Chris covered exercise/tax liability with 676 shares, decreasing direct ownership by 2% to 36,901 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 200d
  SEC Form 4 filed by Officer Sherman Darren

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 235d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 3,452 shares, decreasing direct ownership by 0.76% to 451,493 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 235d
  Principal Accounting Officer Aiello Joshua covered exercise/tax liability with 241 shares, decreasing direct ownership by 1% to 18,885 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 235d
  Officer Sherman Darren covered exercise/tax liability with 5,588 shares, decreasing direct ownership by 0.66% to 840,569 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 256d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 8,670 shares, decreasing direct ownership by 2% to 454,945 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 256d
  Officer Hochman David P covered exercise/tax liability with 43,638 shares, decreasing direct ownership by 7% to 572,467 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 272d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 3,071 shares, decreasing direct ownership by 0.66% to 463,615 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 272d
  Officer Sherman Darren covered exercise/tax liability with 40,340 shares, decreasing direct ownership by 5% to 846,157 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 284d
  Officer Hochman David P covered exercise/tax liability with 6,566 shares, decreasing direct ownership by 0.54% to 607,822 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 340d
  Principal Accounting Officer Aiello Joshua covered exercise/tax liability with 203 shares, decreasing direct ownership by 1% to 19,126 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 340d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 16,102 shares, decreasing direct ownership by 3% to 466,686 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 340d
  Officer Hochman David P covered exercise/tax liability with 43,638 shares, decreasing direct ownership by 6% to 611,105 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 354d
  Officer Sherman Darren covered exercise/tax liability with 40,340 shares, decreasing direct ownership by 4% to 886,497 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 382d
  Chief Financial Officer Taylor Andrew Lawrence was granted 80,000 shares, increasing direct ownership by 20% to 480,788 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 382d
  Director Aryeh Jason was granted 15,000 shares, increasing direct ownership by 16% to 107,482 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 382d
  Officer Sherman Darren was granted 120,000 shares, increasing direct ownership by 15% to 923,837 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 382d
  Director Connealy Pamela Ann was granted 15,000 shares, increasing direct ownership by 44% to 48,711 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 382d
  Director Mack John Prosper was granted 15,000 shares, increasing direct ownership by 59% to 40,286 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 382d
  Director Fain Eric S was granted 15,000 shares (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 382d
  Director Cleary Chris was granted 15,000 shares, increasing direct ownership by 66% to 37,577 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 382d
  Officer Hochman David P was granted 200,000 shares, increasing direct ownership by 18% to 645,460 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 382d
  Director Pacitti David was granted 15,000 shares, increasing direct ownership by 50% to 44,968 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 382d
  Principal Accounting Officer Aiello Joshua was granted 15,000 shares, increasing direct ownership by 347% to 19,329 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 384d
  SEC Form 4 filed by Large owner Rtw Investments, Lp

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 424d
  Director Fain Eric S sold $8,183 worth of shares (2,683 units at $3.05) (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 424d
  Director Aryeh Jason was granted 12,422 shares, increasing direct ownership by 16% to 92,482 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 425d
  Director Cleary Chris was granted 12,422 shares, increasing direct ownership by 122% to 22,577 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 425d
  Director Mack John Prosper was granted 12,422 shares, increasing direct ownership by 97% to 25,286 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 425d
  Director Connealy Pamela Ann was granted 12,422 shares, increasing direct ownership by 58% to 33,711 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 425d
  Director Fain Eric S was granted 12,422 shares (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 425d
  Director Pacitti David was granted 12,422 shares, increasing direct ownership by 71% to 29,968 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 431d
  Principal Accounting Officer Aiello Joshua covered exercise/tax liability with 393 shares, decreasing direct ownership by 8% to 4,329 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 438d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 28,172 shares, decreasing direct ownership by 7% to 400,788 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 438d
  Officer Hochman David P covered exercise/tax liability with 39,709 shares, decreasing direct ownership by 6% to 545,460 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 452d
  Officer Sherman Darren covered exercise/tax liability with 45,843 shares, decreasing direct ownership by 5% to 803,837 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)

Other OBIO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends